Hra Pharma
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$2.4Mgeneral payments (2019-2025)
$202Kresearch payments (2019-2025)
41clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Stephanie Sober | Philadelphia, PA | Obstetrics & Gynecology | $1,757,989.22 |
| Eric Brass | Torrance, CA | General Practice | $169,701.85 |
| Rachel Steward | San Bernardino, CA | Obstetrics & Gynecology | $81,700.00 |
| Carolyn Westhoff | New York, NY | Obstetrics & Gynecology | $64,431.00 |
| Curtis Rosebraugh | Ashton, MD | Internal Medicine | $36,587.50 |
| Gregory Burkhart | Reston, VA | Public Health & General Preventive Medicine | $35,352.59 |
| Beverly Moy | Boston, MA | Hematology & Oncology | $27,501.88 |
| Paul Watkins | Chapel Hill, NC | Gastroenterology (Internal Medicine) | $19,247.03 |
| Philip Hanno | Stanford, CA | Urology | $10,000.00 |
| Andrew Seidman | New York, NY | Medical Oncology | $9,200.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.